3004.90.92.47/Rocuronium Bromide Injection 50 mg/5 mL Vial/Japan

Rocuronium Bromide Injection 50 mg/5 mL Vial from Japan

This is a sterile injectable solution of rocuronium bromide, a non-depolarizing neuromuscular blocking agent used to facilitate tracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. It falls under HTS 3004.90.92.47 as a medicament containing rocuronium or its salts, put up in measured doses for therapeutic use primarily affecting the central nervous system via peripheral neuromuscular blockade.

Duty Rate — Japan → United States

15%

Rate breakdown

9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter

9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter

Calculate with your customs value Verify with the Tariff Assistant

Import Tips

• Obtain FDA approval and ensure product meets cGMP standards for sterile injectables; include Certificate of Analysis (CoA) verifying rocuronium bromide content

• Provide detailed batch testing documentation for potency, sterility, and endotoxin levels to avoid CBP holds at entry

• Label clearly with NDC code, lot number, and expiration date; beware of misclassification as general anesthetics under different subheadings